These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 13194253)

  • 1. Evaluation of flicker fusion photometry its use in prediction of pre-eclampsia.
    GILLIM DL
    Obstet Gynecol; 1954 Sep; 4(3):264-9. PubMed ID: 13194253
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of the flicker fusion threshold as a diagnostic aid in cases of toxemia of pregnancy.
    HILBERT B
    Ned Tijdschr Verloskd Gynaecol; 1953; 53(4):211-25. PubMed ID: 13154489
    [No Abstract]   [Full Text] [Related]  

  • 3. Flicker fusion threshold; nitroglycerine response as a screening test for toxemia of pregnancy.
    RODDICK JW; BENARON HB
    Obstet Gynecol; 1954 Sep; 4(3):260-3. PubMed ID: 13194252
    [No Abstract]   [Full Text] [Related]  

  • 4. Flicker photometry and toxemia of pregnancy.
    PERL FL; OPER A
    Am J Obstet Gynecol; 1956 Jan; 71(1):107-12. PubMed ID: 13282978
    [No Abstract]   [Full Text] [Related]  

  • 5. A statistical evaluation of the nitroglycerine flicker-fusion threshold test and the weight-gain sign in the prediction of the clinical syndrome of pre-eclampsia.
    GARDINER J; HERDAN G
    J Obstet Gynaecol Br Emp; 1957 Oct; 64(5):691-9. PubMed ID: 13476260
    [No Abstract]   [Full Text] [Related]  

  • 6. The nitroglycerin flicker fusion threshold test in toxemia of pregnancy.
    BRILL HM; LONG JS; KLAWANS AH; GOLDEN M; SEAMAN I
    Am J Obstet Gynecol; 1952 Dec; 64(6):1201-10. PubMed ID: 12996578
    [No Abstract]   [Full Text] [Related]  

  • 7. The significance of the nitroglycerine flicker fusion response in normal subjects and in pregnancy.
    MORRIS N; TOMKINSON JS; O'CONNOR BJ
    J Obstet Gynaecol Br Emp; 1953 Oct; 60(5):680-3. PubMed ID: 13109597
    [No Abstract]   [Full Text] [Related]  

  • 8. Urine albumin concentration and albumin-to-creatinine ratio at 11(+0) to 13(+6) weeks in the prediction of pre-eclampsia.
    Poon LC; Kametas N; Bonino S; Vercellotti E; Nicolaides KH
    BJOG; 2008 Jun; 115(7):866-73. PubMed ID: 18485165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differential sensitivity of vision to flicker rate].
    Rozhentsov VV
    Med Tekh; 2005; (2):33-5. PubMed ID: 15881436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk.
    Khalil A; Cowans NJ; Spencer K; Goichman S; Meiri H; Harrington K
    Prenat Diagn; 2009 Aug; 29(8):781-9. PubMed ID: 19418482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flicker photometry and electrocardiography: a correlation.
    GOLDEN LH; CORDASCO EM
    N Y State J Med; 1952 Sep; 52(17:1):2157-8. PubMed ID: 13002804
    [No Abstract]   [Full Text] [Related]  

  • 12. A combined technique for predicting pre-eclampsia: concurrent measurement of uterine perfusion and analysis of heart rate and blood pressure variability.
    Walther T; Wessel N; Malberg H; Voss A; Stepan H; Faber R
    J Hypertens; 2006 Apr; 24(4):747-50. PubMed ID: 16531804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the association between all components of the metabolic syndrome and pre-eclampsia.
    Srinivas SK; Sammel MD; Bastek J; Ofori E; Andrela CM; Wolfe ML; Reilly M; Elovitz MA
    J Matern Fetal Neonatal Med; 2009 Jun; 22(6):501-9. PubMed ID: 19479639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of risk for the development of pre-eclampsia by maternal characteristics and uterine artery Doppler.
    Papageorghiou AT; Yu CK; Erasmus IE; Cuckle HS; Nicolaides KH
    BJOG; 2005 Jun; 112(6):703-9. PubMed ID: 15924523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum advanced oxidation protein products, myeloperoxidase and ascorbic acid in pre-eclampsia and eclampsia.
    Noyan T; Güler A; Sekeroğlu MR; Kamaci M
    Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):486-91. PubMed ID: 17116052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis.
    Koopmans CM; van Pampus MG; Groen H; Aarnoudse JG; van den Berg PP; Mol BW
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):8-14. PubMed ID: 19540647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-eclampsia and eclampsia.
    MOODY MC
    Rocky Mt Med J; 1957 May; 54(5):447-52; passim. PubMed ID: 13432581
    [No Abstract]   [Full Text] [Related]  

  • 18. [Symptomatology and therapy of pre-eclampsia and eclampsia].
    TAPFER S
    Wien Klin Wochenschr; 1955 Mar; 67(9):153-8. PubMed ID: 14374414
    [No Abstract]   [Full Text] [Related]  

  • 19. The complications of hypertension in pregnancy.
    von Dadelszen P; Menzies J; Magee LA
    Minerva Med; 2005 Aug; 96(4):287-302. PubMed ID: 16179895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 10-2849AA genotype protects against pre-eclampsia.
    de Groot CJ; Jansen MW; Bertina RM; Schonkeren JJ; Helmerhorst FM; Huizinga TW
    Genes Immun; 2004 Jun; 5(4):313-4. PubMed ID: 15085177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.